Navigation Links
Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
Date:11/11/2008

Study highlights:

- Interferon eliminated specific causes of some viruses in heart failure patients, improving their clinical outcomes.

- Treatment improved cardiac function and quality of life and showed no apparent safety concerns.

NEW ORLEANS, Nov. 11 /PRNewswire-USNewswire/ -- Giving interferon to heart failure patients with evidence of a chronic viral infection safely eliminated two viruses from their systems and reduced levels of a third virus. Additionally, there were trends toward improved cardiac function and quality of life, but these did not reach significance at 24 weeks, researchers reported at the American Heart Association's Scientific Sessions 2008. Results from the Effect of Subcutaneous Treatment with Interferon-Beta-1b over 24 weeks on Safety, Virus Elimination and Clinical Outcome in Patients with Chronic Viral Cardiomyopathy study were presented as a late-breaking clinical trial.

"These results from our randomized trial provide the first evidence that interferon beta-1b (IFNB-1b) treatment eliminates cardiotropic viruses and may improve the clinical outcomes of patients with chronic enteroviral and adenoviral heart disease," said Heinz Peter Schultheiss, M.D., the lead author of the study and a professor of medicine in the Department of Cardiology and Pneumology at Charite - University Medicine of Berlin, Campus Benjamin Franklin in Berlin, Germany.

The double-blind Phase II study included 143 patients at 31 medical centers in seven European countries.

Investigators also found a reduction in the viral load for parvovirus, but not evidence for elimination.

Researchers found that patients infected with adenovirus, enterovirus and/or parvovirus B19 who received IFNB-1b were about twice as likely to have improved symptoms 12 weeks after treatment ended. They found that 38.6 percent of the interferon patients had an improved New York Heart Association (NYHA) functional classification as compared
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Study shows that high-dose, high-frequency interferon produces no additional benefit
2. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Interferon does not slow or stop hepatitis C from worsening, study finds
5. For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution
6. Ultra-High Pressure Processing Eliminates Salmonella in Fresh Tomatoes
7. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
8. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Doctor Recommends New Powerful Natural Antiviral Against the Flu
11. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...NSAS CITY, Mo., Dec. 4 The large, ...al Association of Free Clinics (NAFC) in Kansas Ci...ick but also for anyone who is uninsured and has n... health clinic will receive preventive primary car...ious large free clinic events this fall in Houston...
(Date:12/4/2009)...ASHINGTON, Dec. 4 While... control health care costs, Leapfrog,s purchaser m...mple -- delivering the best quality care in the na...ncy. Thirty-four urban, eight children,s and three... Hospitals, based on results from The Leapfrog Hos...
(Date:12/4/2009)...ORD, Calif. A new study shows that muscle cells g... to squeeze shut properly. The work, performed in ...s with conditions such as gastric reflux and fecal...trengthen sphincters, which are the bands of muscl...nal tract. Weakness in these areas can cause gastr...
(Date:12/4/2009)...5 million Americans are recruited annually to part...ce for Human Research Protection (AHRP), and most ... Research institutions view payments to voluntee...ompensation for potential risks related to partici...that volunteers have a very different view of clin...
(Date:12/4/2009)...hether procedure done immediately or 3 weeks later...Day News) -- Timing of surgical repair or reconstr...affect patient outcome, a new study has found. ,...matic knee dislocations that can occur in high-imp...time to perform surgery to repair these injuries h...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...sumption of illicit or noncommercial alcohol is wi...es significantly to the global burden of disease, ...ternational Center for Alcohol Policies (ICAP). Th...rfeit or unregistered products, in three regions: ...
...te radio,channel created for medical professionals...ewest strategic programming partnership with the A...professional association of medical,directors, att...a,great opportunity to reach a large audience abou...
...Inc., a leader,in the development of predictive dr...tional funding to expand the development and comme...ic test that helps physicians select the,most effe... Adams Capital Management, Quaker BioVentures, Bir...
...a mastectomy who undergo radiation therapy after i...reconstruction provides fewer long-term complicati...er and implant reconstruction, according to a stud...utic Radiology and Oncology., After undergoing a m...
...ay be key, study says , , THURSDAY, Nov. 2...keup of alcoholics may affect how much they drink,...brain,s control of serotonin, a mood-influencing n...hat person, said study co-author Ming D. Li, head ...
...LC today,announced the acquisition of Terrace Inte...lth, of Redlands, CA, a leading national distribut... integrative healthcare market. , The combin...tional supplements market. "This new organization ...
Other Medicine News:Health News:Report finds extensive use of illicit alcohol 2Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:Genetic Trait Linked to Alcoholism 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3
(Date:12/4/2009)...Newswire-FirstCall/ -- Northwest Biotherapeutics, ...: NWBO) announced today that the US Patent and Tra...n a system for automation of the initial stages of...apeutic cancer vaccines. These initial manufactur...of dendritic cells (which are the critical ingredi...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Allen Medical Systems, a ... ), today announced the launch of its new Allen Am...siness website www.AllenAmatech.com . ,, Th...dentity and includes an online version of the new ...sign specifications for the products. "We hope to ...
(Date:12/3/2009)...ec. 3 Ted Karkus, Chairm...GLY ) www.quigleyco.com announced today that the...tunities to develop prescription pharmaceutical an... best interests to focus primarily on the OTC/Pers...ot limited to its Cold-EEZE® and Kids-EEZE...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Many Childhood Cancer Survivors Never Marry 59131 1Many Childhood Cancer Survivors Never Marry 59131 2Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 1Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 1ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 3ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 4
...d ICAAC/IDSA meetings this week, SAN DIEGO, Oct. ...itional clinical and preclinical results with MP-3...n inhaled solution delivered by,an Investigational... (CF),and chronic obstructive pulmonary disease (C... MP-376 was well tolerated at all dose levels test...
...rst Responses in Solid Tumours Reported., Aurora ... are,implicated in both the onset and progression ... Aurora kinase inhibitors will be presented today ...I-AACR Symposium "Molecular,Targets and Cancer The...8,in Geneva. Dr Laffranchi, Director Clinical Rese...
Other Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: